Psoriasis is a chronic immune-mediated inflammatory skin disorder affecting children and adults. To date no approved biomarkers for diagnosis of this disease and follow up of patients have been...
Read More »EXOSOME NEWS
Post-doc position available – Clinical and Translational Research
We are seeking a Post-Doctoral Scientist -This position is in the Center for Clinical and Translational Research. We are seeking a motivated postdoctoral scholar to join our NIH-funded lab group that ...
Read More »Exosome Isolation from Cell Culture Media- CBEC Cell Block
For more information on Cell Blocks and written protocols go to www.cellbioed.com. A network of faculty and students working on incorporating cell culture-based research into the classroom...
Read More »Extracellular vesicle fusion visualized by cryo-EM
Extracellular vesicles (EVs) transfer bioactive molecules between cells in a process reminiscent of enveloped viruses. EV cargo delivery is thought to occur by protein-mediated and pH-dependent...
Read More »Human amniotic fluid stem cell-extracellular vesicles show promising transient potential for cardiomyocyte renewal
Cardiomyocyte renewal represents an unmet clinical need for cardiac regeneration. Stem cell paracrine therapy has attracted increasing attention to resurge rescue mechanisms within the heart. University of...
Read More »Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer
Despite the significance of colonoscopy for early diagnosis of colorectal adenocarcinoma (CRC), population-wide screening remains challenging, mainly because of low acceptance rates...
Read More »Pivoting Novel Exosome-Based Technologies for the Detection of SARS-CoV-2
The National Institutes of Health (NIH) launched the Rapid Acceleration of Diagnostics (RADx) initiative to meet the needs for COVID-19 diagnostic and surveillance testing, and to speed its innovation in the development, commercialization, and...
Read More »Coya Therapeutics Secures $10 Million Financing to Advance Clinical and Pre-Clinical Pipeline of Treg-Derived Exosome Therapeutics
Coya Therapeutics, a clinical-stage biotechnology company developing multiple first-in-class and best-in-class approaches that enhance regulatory T cell (Treg) function, today announced that it has raised approximately $10.3 million from institutional and...
Read More »A biotinylated antibody biosensor for the ultrasensitive detection of exosomal glioblastoma biomarkers
Glioblastoma (GBM) is an incurable brain tumor in which hypoxic GBM cells (GMs) increase the production and release of exosomes, which are 30-200 nm vesicles crossing the blood-brain-barrier, enabling exosomal biomarkers to be promising targets...
Read More »Jobs
-
Featured Exosome Job – Scientist, Regenerative Medicine – Exosomes
Contribute to our expanding range of translational preventive and regenerative medicine work with exosomes from different source cells, including iPSCs and many iPSC-derived cell types like MSCs, HSCs,...
Read More » -
Post-doc position available – Clinical and Translational Research
-
Featured Exosome Job – Research Associate II, Exosome Engineering, Protein Sciences
-
Postdoc position available – microchip-based exosome sensors
-
Post-doc position available – new pathways in endosome formation and extracellular vesicle secretion in metastasis
Industry News
-
Coya Therapeutics Secures Option Agreement for Exclusive Worldwide Rights to Exosome Engineering Technology from Carnegie Mellon University
Coya Therapeutics announced the execution of an option agreement for exclusive worldwide rights to a novel and proprietary technology platform enabling...
Read More » -
Exosome Engineering Strategies for Cargo Loading and Targeting Delivery
-
Coya Therapeutics Secures $10 Million Financing to Advance Clinical and Pre-Clinical Pipeline of Treg-Derived Exosome Therapeutics
-
Novel assay for early detection of ovarian cancer in extracellular vesicles significantly outperforms current standard test
-
Evox Therapeutics Presents Progress Across its DeliverEX™ Exosome Therapeutics Platform